Tema Cardiovascular and Metabolics ETF (HRTS) Short Interest Ratio & Short Volume $29.02 +0.42 (+1.47%) As of 12:01 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock Tema Cardiovascular and Metabolics ETF Short Interest DataTema Cardiovascular and Metabolics ETF (HRTS) has a short interest of 800 shares, representing 0.04% of the float (the number of shares available for trading by the public). This marks a 14.29% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 11,663 shares to cover all short positions.Current Short Interest800 sharesPrevious Short Interest700 sharesChange Vs. Previous Month+14.29%Dollar Volume Sold Short$22,112.00Short Interest Ratio0.1 Days to CoverLast Record DateApril 15, 2025Outstanding Shares1,900,000 sharesShort Percent of Float0.04%Today's Trading Volume6,840 sharesAverage Trading Volume11,663 sharesToday's Volume Vs. Average59% Short Selling Tema Cardiovascular and Metabolics ETF? Sign up to receive the latest short interest report for Tema Cardiovascular and Metabolics ETF and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartHRTS Short Interest Over TimeHRTS Days to Cover Over TimeHRTS Percentage of Float Shorted Over Time Tema Cardiovascular and Metabolics ETF Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2025800 shares $22,112.00 +14.3%0.0%0.1 $27.64 3/31/2025700 shares $20,531.00 +40.0%0.0%0.1 $29.33 3/15/2025500 shares $14,860.00 -28.6%0.0%0 $29.72 2/28/2025700 shares $21,546.00 +16.7%0.0%0 $30.78 2/15/2025600 shares $18,048.00 -60.0%0.0%0 $30.08 1/31/20251,500 shares $45,645.00 -28.6%N/A0.1 $30.43 1/15/20252,100 shares $60,795.00 -12.5%N/A0.1 $28.95 12/31/20242,400 shares $69,288.00 +20.0%N/A0.2 $28.87 12/15/20242,000 shares $60,860.00 +66.7%N/A0.1 $30.43 11/30/20241,200 shares $39,000.00 -14.3%N/A0.1 $32.50 11/15/20241,400 shares $43,260.00 +180.0%N/A0.1 $30.90 10/31/2024500 shares $16,315.00 -95.4%N/A0 $32.63 10/15/202410,800 shares $367,092.00 -40.3%N/A0.5 $33.99 9/30/202418,100 shares $608,160.00 +81.0%N/A0.8 $33.60 9/15/202410,000 shares $347,700.00 -50.5%N/A0.4 $34.77 8/31/202420,200 shares $713,868.00 +71.2%N/A0.8 $35.34 8/15/202411,800 shares $399,666.00 +43.9%N/A0.4 $33.87 7/31/20248,200 shares $280,850.00 -24.8%N/A0.3 $34.25 7/15/202410,900 shares $386,950.00 No ChangeN/A0.5 $35.50 HRTS Short Interest - Frequently Asked Questions What is Tema Cardiovascular and Metabolics ETF's current short interest? Short interest is the volume of Tema Cardiovascular and Metabolics ETF shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 800 shares of HRTS short. 0.04% of Tema Cardiovascular and Metabolics ETF's shares are currently sold short. Learn More on Tema Cardiovascular and Metabolics ETF's current short interest. What is a good short interest percentage for Tema Cardiovascular and Metabolics ETF? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.04% of Tema Cardiovascular and Metabolics ETF's floating shares are currently sold short. Is Tema Cardiovascular and Metabolics ETF's short interest increasing or decreasing? Tema Cardiovascular and Metabolics ETF saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 800 shares, an increase of 14.3% from the previous total of 700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Tema Cardiovascular and Metabolics ETF's short interest compare to its competitors? 0.04% of Tema Cardiovascular and Metabolics ETF's shares are currently sold short. Here is how the short interest of companies compare to Tema Cardiovascular and Metabolics ETF: Global X Aging Population ETF (0.03%), Tradr 2X Short Innovation Daily ETF (7.32%), Tradr 2X Long Innovation ETF (5.25%), Fidelity Disruptive Communications ETF (0.06%), Fidelity Disruptive Medicine ETF (0.00%), Global X Genomics & Biotechnology ETF (0.10%), Procure Space ETF (6.02%), Tema Oncology ETF (0.10%), AOT Growth & Innovation ETF (0.36%), Siren Nasdaq NexGen Economy ETF (0.35%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short Tema Cardiovascular and Metabolics ETF stock? Short selling HRTS is an investing strategy that aims to generate trading profit from Tema Cardiovascular and Metabolics ETF as its price is falling. HRTS shares are trading up $0.42 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Tema Cardiovascular and Metabolics ETF? A short squeeze for Tema Cardiovascular and Metabolics ETF occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of HRTS, which in turn drives the price of the stock up even further. How often is Tema Cardiovascular and Metabolics ETF's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HRTS, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies AGNG Short Interest Data SARK Short Interest Data TARK Short Interest Data FDCF Short Interest Data FMED Short Interest Data GNOM Short Interest Data UFO Short Interest Data CANC Short Interest Data AOTG Short Interest Data BLCN Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:HRTS) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeWhile everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Cardiovascular and Metabolics ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Cardiovascular and Metabolics ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.